Xianbin Su

1.0k total citations
37 papers, 539 citations indexed

About

Xianbin Su is a scholar working on Molecular Biology, Cancer Research and Pollution. According to data from OpenAlex, Xianbin Su has authored 37 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Pollution. Recurrent topics in Xianbin Su's work include Single-cell and spatial transcriptomics (6 papers), Cancer Genomics and Diagnostics (5 papers) and Immunotherapy and Immune Responses (4 papers). Xianbin Su is often cited by papers focused on Single-cell and spatial transcriptomics (6 papers), Cancer Genomics and Diagnostics (5 papers) and Immunotherapy and Immune Responses (4 papers). Xianbin Su collaborates with scholars based in China, Australia and United States. Xianbin Su's co-authors include Ze‐Guang Han, Jean Yang, Yi Shi, Yingxin Lin, Shila Ghazanfar, Jimmy S. H. Tsang, Kunyan He, Johann A. Gagnon-Bartsch, Pengyi Yang and John T. Ormerod and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Xianbin Su

34 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianbin Su China 13 349 89 68 50 46 37 539
John P. Stone United Kingdom 14 148 0.4× 69 0.8× 45 0.7× 95 1.9× 15 0.3× 27 650
Yating Zhang China 11 166 0.5× 106 1.2× 88 1.3× 163 3.3× 9 0.2× 30 569
Yasmina Bauer Switzerland 10 252 0.7× 59 0.7× 44 0.6× 51 1.0× 9 0.2× 12 589
Zhiqiang Zhu China 12 156 0.4× 35 0.4× 67 1.0× 52 1.0× 5 0.1× 32 506
Rihao Qu United States 11 351 1.0× 137 1.5× 199 2.9× 81 1.6× 4 0.1× 23 661
Narisorn Kongruttanachok Thailand 10 494 1.4× 114 1.3× 74 1.1× 86 1.7× 7 0.2× 20 679
Zhiyu Tang China 16 177 0.5× 82 0.9× 76 1.1× 213 4.3× 8 0.2× 45 643
Masaru Koido Japan 12 226 0.6× 56 0.6× 48 0.7× 46 0.9× 16 0.3× 30 523
Zhongxi Huang China 13 324 0.9× 158 1.8× 53 0.8× 123 2.5× 4 0.1× 34 556

Countries citing papers authored by Xianbin Su

Since Specialization
Citations

This map shows the geographic impact of Xianbin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianbin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianbin Su more than expected).

Fields of papers citing papers by Xianbin Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianbin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianbin Su. The network helps show where Xianbin Su may publish in the future.

Co-authorship network of co-authors of Xianbin Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xianbin Su. A scholar is included among the top collaborators of Xianbin Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianbin Su. Xianbin Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Shihao, Xianbin Su, Ziyao Chen, & Ze‐Guang Han. (2025). De Novo Detection of Clonal Structure and Evolution in Single-Cell and Spatial Transcriptomes. International Journal of Molecular Sciences. 26(23). 11428–11428.
3.
Lu, Xuan, Ying Chen, Yi Shi, et al.. (2025). Exercise and exerkines: Mechanisms and roles in anti-aging and disease prevention. Experimental Gerontology. 200. 112685–112685. 11 indexed citations
4.
Su, Peipei, et al.. (2024). Gene doping detection in the era of genomics. Drug Testing and Analysis. 16(12). 1468–1478. 7 indexed citations
5.
Peng, Wei, Rong Cheng, Hao Liu, Dongmei Liu, & Xianbin Su. (2024). Highly Efficient Continuous Flow Liquid-Phase Peptide Synthesis Using a Soluble Hydrophobic Tag. Chinese Journal of Organic Chemistry. 44(9). 2876–2876. 1 indexed citations
6.
Li, Ruihong, et al.. (2023). Heavy metal contamination in Shanghai agricultural soil. Heliyon. 9(12). e22824–e22824. 13 indexed citations
7.
Cheng, Sheng, Man Zhang, Shihao Bai, et al.. (2023). Single‐cell RNA sequencing reveals the heterogeneity and intercellular communication of hepatic stellate cells and macrophages during liver fibrosis. SHILAP Revista de lepidopterología. 4(5). e378–e378. 22 indexed citations
8.
Su, Xianbin, Shihao Bai, Gangcai Xie, et al.. (2022). Accurate tumor clonal structures require single‐cell analysis. Annals of the New York Academy of Sciences. 1517(1). 213–224. 4 indexed citations
9.
Wang, Lan, Qing Luo, Xianbin Su, et al.. (2022). Inhibition of Arid1a increases stem/progenitor cell-like properties of liver cancer. Cancer Letters. 546. 215869–215869. 10 indexed citations
10.
Wu, Jiaoxiang, Kunyan He, Zhuangzhuang Zhang, et al.. (2021). LZP is required for hepatic triacylglycerol transportation through maintaining apolipoprotein B stability. PLoS Genetics. 17(2). e1009357–e1009357. 15 indexed citations
11.
He, Kunyan, Guangxing Wang, Linan Zhao, et al.. (2021). Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion. Frontiers in Pharmacology. 12. 775602–775602. 9 indexed citations
12.
Su, Xianbin, Qi Long, Juanjie Bo, et al.. (2020). Mutational and transcriptomic landscapes of a rare human prostate basal cell carcinoma. The Prostate. 80(6). 508–517. 14 indexed citations
13.
Shi, Yi, Luming Meng, Xianbin Su, et al.. (2020). A novel neoantigen discovery approach based on chromatin high order conformation. BMC Medical Genomics. 13(S6). 62–62. 3 indexed citations
14.
Ghazanfar, Shila, Yingxin Lin, Xianbin Su, et al.. (2020). Investigating higher-order interactions in single-cell data with scHOT. Nature Methods. 17(8). 799–806. 43 indexed citations
15.
Lin, Yingxin, Shila Ghazanfar, Kevin Wang, et al.. (2019). scMerge leverages factor analysis, stable expression, and pseudoreplication to merge multiple single-cell RNA-seq datasets. Proceedings of the National Academy of Sciences. 116(20). 9775–9784. 110 indexed citations
16.
Su, Xianbin, Yi Shi, Ruihong Li, et al.. (2019). Application of qPCR assays based on haloacids transporter gene dehp2 for discrimination of Burkholderia and Paraburkholderia. BMC Microbiology. 19(1). 36–36. 3 indexed citations
17.
Su, Xianbin, Yi Shi, Xin Zou, et al.. (2017). Single-cell RNA-Seq analysis reveals dynamic trajectories during mouse liver development. BMC Genomics. 18(1). 946–946. 54 indexed citations
18.
Su, Xianbin, et al.. (2016). Transport of haloacids across biological membranes. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1858(12). 3061–3070. 7 indexed citations
19.
Su, Xianbin, Ruihong Li, & Jimmy S. H. Tsang. (2016). The 228 bp upstream non-coding region of haloacids transporter gene dehp2 has regulated promoter activity. Gene. 593(2). 322–329. 2 indexed citations
20.
Shi, Yi, et al.. (2016). Chromatin accessibility contributes to simultaneous mutations of cancer genes. Scientific Reports. 6(1). 35270–35270. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026